Capital Fund Management S.A. Pacific Biosciences Of California, Inc. Call Options Transaction History

Capital Fund Management S.A.

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$1.36 - $3.65 $228,616 - $613,565	-168,100 Reduced 49.3%	172,900 $236,000
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $274,912 - $748,979	78,100 Added 29.71%	341,000 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $1.15 Million - $1.99 Million	192,300 Added 272.38%	262,900 $2.58 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $178,591 - $302,281	21,700 Added 44.38%	70,600 $589,000
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $78,763 - $110,995	7,900 Added 19.27%	48,900 $650,000
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $325,540 - $492,820	41,000 New	41,000 $474,000
Q1 2022 May 12, 2022	SELL	$8.43 - $20.9 $134,037 - $332,310	-15,900 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$19.26 - $30.08 $425,646 - $664,768	-22,100 Reduced 58.16%	15,900 $325,000
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $268,488 - $378,216	-10,800 Reduced 22.13%	38,000 $970,000
Q2 2021 Aug 12, 2021	BUY	$22.3 - $36.02 $102,580 - $165,692	4,600 Added 10.41%	48,800 $1.71 Million
Q1 2021 May 14, 2021	BUY	$26.38 - $51.15 $1.17 Million - $2.26 Million	44,200 New	44,200 $1.47 Million

257

234M

1.02M

965K

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $366M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.